Skip to search formSkip to main contentSkip to account menu

Recurrent Endometrial Cancer

Known as: Recurrent Corpus Uteri Cancer, carcinoma of the endometrium, recurrent, recurrent cancer of the endometrium 
Reemerging uterine corpus carcinoma after a period of remission.
National Institutes of Health

Related topics

Related topics

12 relations
Body of uterusEndometriumEpithelial CellsEpithelium

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
GOG 3007, a randomized phase II (RP2) trial of everolimus and letrozole (EL) or hormonal therapy (medroxyprogesterone acetate/tamoxifen, PT) in women with advanced, persistent or recurrent…
2007
2007
RASSF1A methylation and K-ras and B-raf mutations and recurrent endometrial cancer.
BACKGROUND Aberrations in mediators of Ras signaling may increase the risk of developing recurrent endometrial carcinoma… 
Review
2005
Review
2005
Carboplatin plus paclitaxel in the treatment of advanced or recurrent endometrial carcinoma
Purpose To evaluate the efficacy and safety of the combination of carboplatin plus paclitaxel in patients with advanced… 
Review
2002
Review
2002
Current status and future innovations of hormonal agents, chemotherapy and investigational agents in endometrial cancer
The median survival of women with advanced or recurrent endometrial cancer is less than one year. Only half the women with early… 
Highly Cited
2000
Highly Cited
2000
Paclitaxel and cisplatin in advanced or recurrent carcinoma of the endometrium: long-term results of a phase II multicenter study.
OBJECTIVES Both paclitaxel and cisplatin have moderate activity in patients with metastatic or recurrent carcinoma of the… 
Highly Cited
1996
Highly Cited
1996
Taxol is active in platinum-resistant endometrial adenocarcinoma.
Taxol, 170 mg/m2 by 3-h infusion every 3 weeks, was administered to seven patients with primarily advanced or recurrent… 
1996
1996
A phase II trial of prolonged oral etoposide (VP-16) as second-line therapy for advanced and recurrent endometrial carcinoma: a Gynecologic Oncology Group study.
Prolonged oral etoposide is an active regimen in small and nonsmall cell carcinoma of the lung, carcinomas of the breast and… 
Review
1990
Review
1990
Circadian‐Timed Combination Doxorubicin‐Cisplatin Chemotherapy for Advanced Endometrial Carcinoma: A Phase II Study of the Gynecologic Oncology Group
Highly Cited
1989
Highly Cited
1989
Results of radiotherapy in recurrent endometrial carcinoma: a retrospective analysis of 51 patients.
Highly Cited
1984
Highly Cited
1984
Multidrug Treatment of Advanced and Recurrent Endometrial Carcinoma: A Gynecologic Oncology Group Study
Patients (358) with advanced (FIGO stages III and IV) or recurrent endometrial cancer were treated with one of two regimens: 1… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)